Many of us are dry eye sufferers. But not everyone is doomed to live with red-eyed irritation forever. We recently discovered ...

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic ...

Millions of Americans suffer from dry eye disease, an often-overlooked condition that can significantly impact daily life. In ...

Dry eye syndrome, a condition affecting millions of Americans each year, continues to present a frustrating challenge for ...

A new article in JOJ Ophthalmology confirms Tixel i® provides sustained, strong clinical outcomes for patients with ...

Dr. Noaman Sanni, a leading ophthalmologist and CEO of Center for Sight New York, has witnessed significant patient and ...

In this episode of CT BUZZ, Reporter Jillian Andrews sat down with Dr. Donald Higgins, Optometrist and Medical Director of ...

Tear film stability, tear production, ocular surface health, and symptoms were all significantly improved with the use of ...

Dr. Steven Sarkisian leads Oklahoma Eye Surgeons in cutting-edge treatments like MIGS and robotic cataract surgery, restoring vision across the state.

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.